z-logo
open-access-imgOpen Access
Structure, Content and Reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) Substance Use Sections
Author(s) -
G. Lachner,
HansUlrich Wïttchen,
Axel Perkonigg,
Alexandra Holly,
Peter Schuster,
U. Wunderlich,
Dilek Türk,
Ela Garczynski,
Hildegard Pfister
Publication year - 1998
Publication title -
european addiction research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.862
H-Index - 54
eISSN - 1421-9891
pISSN - 1022-6877
DOI - 10.1159/000018922
Subject(s) - cidi , kappa , substance abuse , craving , psychiatry , reliability (semiconductor) , clinical psychology , psychology , alcohol abuse , medicine , addiction , anxiety disorder , linguistics , philosophy , power (physics) , physics , quantum mechanics , anxiety
After reviewing currently available diagnostic assessment instruments for substance use disorders this paper describes the format and structure of the Munich-Composite International Diagnostic Interview (M-CIDI) substance disorder section. In addition, the test-retest reliability of diagnoses and criteria for nicotine, alcohol, illegal and prescription drugs, is reported. Findings obtained in community sample of adolescents and young adults indicate that the substance section is acceptable for almost all types of respondents, efficient in terms of time and ease of administration as well as reliable in terms of consistency of findings over time. The test-retest reliability over a period of an average of 1 month, as examined by two independent interviewers indicates good-to-excellent kappa values for all substance disorders assessed, with significant kappa values ranging between 0.55 for drug abuse and 0.83 for alcohol abuse. There was also fairly consistently high agreement for the assessment of single DSM-IV diagnostic criteria for abuse and dependence as well as the M-CIDI quantity-frequency and time-related questions. To conclude, although - unlike previous studies - this study was conducted in a community sample and not in patients and used considerably longer time intervals of more than a month between investigations, our M-CIDI reliability findings are at least as high as those from previous studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom